(CRISPR/Cas9 and small molecules for targeting sperm function and fertilization) The overall goals of Project 2 are to use CRISPR/Cas9 to understand the formation of functional sperm and identify small-molecule probes and preclinical candidates to target fertilization-required proteins for a contraceptive effect in vivo. Population growth is a major worldwide issue, and our resources cannot continue to sustain these population increases, and because of this, NICHD has made contraception a priority focus area. Because our group is focused on the development of contraceptives that specifically target sperm and fertilization, these germ cell-selective contraceptives would eliminate unwanted side effects. The Ikawa laboratory has developed the CRISPR/Cas9 system to efficiently mutate genes in vivo including the Cetn1 and Prm1 genes required for male fertility. In this P01, we will use CRISPR/Cas9 technology to advance our understanding of fertility pathways in all three Projects and generate useful information to move these target proteins and other related pathway proteins into the DEC-Tec Core for screening. For contraceptive targets in Project 2, we will focus on two sperm-egg fusion transmembrane/signaling proteins and four sperm motility- related proteins that we have shown are evolutionarily-conserved and required only for male fertility. The Ikawa laboratory has effectively used the CRISPR/Cas9 system to generate mutations in over 200 mouse genes including the genes described in this proposal. This strategy has also successfully produced knockin of tag sequences into loci. We have used CRISPR/Cas9 independently and in collaboration with the Matzuk laboratory (Project 1) to uncover proteins required for sperm-egg fusion and sperm motility. Functional analysis of these mouse models will help not only to decipher the mechanisms by which these proteins function in sperm-egg fusion and sperm motility but also to develop contraceptive drugs to target these essential pathways. The screening of small molecules using the DEC-TEC Core will accelerate this process. Our overall hypothesis is that CRISPR/Cas9 and DEC-Tec will help us to understand the network of interactions of these proteins for sperm function, rapidly identify multiple small molecules that are directed at these essential spermatogenic proteins, and create an assortment of contraceptives for men and women.
The Specific Aims of Project 2 are: 1) Manipulate the mouse genome and characterize the interrelationship of sperm-egg fusion proteins; 2) Use CRISPR/Cas9 to study the mechanism of action of novel testis-specific proteins; and 3) Use DEC-Tec to identify small-molecule drug-like probes and preclinical candidates to inhibit sperm motility-specific and fertilization-specific proteins for a contraceptive effect in vivo. The success of Project 2 and this P01 grant relies on the continued collaborations of Project 2 with Dr. Matzuk in Project 1, Drs. Sonnenburg, Lamb, and Huang in Project 3, and the scientists in the DEC-Tec Core. Our goal is to develop multiple unique transgenic models and non-hormonal contraceptives for mechanistic and pharmacologic studies in vivo in this P01 grant.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
1P01HD087157-01A1
Application #
9278440
Study Section
Special Emphasis Panel (ZHD1-DSR-L (MM))
Project Start
2017-05-01
Project End
2022-04-30
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
1
Fiscal Year
2017
Total Cost
$176,144
Indirect Cost
$14,625
Name
Baylor College of Medicine
Department
Type
Domestic Higher Education
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Satouh, Yuhkoh; Ikawa, Masahito (2018) New Insights into the Molecular Events of Mammalian Fertilization. Trends Biochem Sci 43:818-828
Nozawa, Kaori; Satouh, Yuhkoh; Fujimoto, Takao et al. (2018) Sperm-borne phospholipase C zeta-1 ensures monospermic fertilization in mice. Sci Rep 8:1315
Fujihara, Yoshitaka; Oji, Asami; Kojima-Kita, Kanako et al. (2018) Co-expression of sperm membrane proteins CMTM2A and CMTM2B is essential for ADAM3 localization and male fertility in mice. J Cell Sci 131:
Niedenberger, Bryan A; Cook, Kenneth; Baena, Valentina et al. (2018) Dynamic cytoplasmic projections connect mammalian spermatogonia in vivo. Development 145:
Fujihara, Yoshitaka; Miyata, Haruhiko; Ikawa, Masahito (2018) Factors controlling sperm migration through the oviduct revealed by gene-modified mouse models. Exp Anim 67:91-104
Nishimasu, Hiroshi; Shi, Xi; Ishiguro, Soh et al. (2018) Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361:1259-1262
Abbasi, Ferheen; Miyata, Haruhiko; Shimada, Keisuke et al. (2018) RSPH6A is required for sperm flagellum formation and male fertility in mice. J Cell Sci 131:
Fujihara, Yoshitaka; Oji, Asami; Larasati, Tamara et al. (2017) Human Globozoospermia-Related Gene Spata16 Is Required for Sperm Formation Revealed by CRISPR/Cas9-Mediated Mouse Models. Int J Mol Sci 18: